Cutting Sales Ties To Physician Grants: More Difficult Than May Appear
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers face an uphill battle to exclude sales staff from the physician grant decision-making process, attorneys agreed at the Medical Device & Diagnostics Marketing Compliance Congress in Washington, D.C
You may also be interested in...
DoJ Probe Into Orthopedic Industry Could Rattle Upward Pricing Trend
Several subpoenas of orthopedic manufacturers by the U.S. attorney's office in Newark, N.J. appear to be aimed at alleviating pricing pressure on hospitals for orthopedic devices
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.